Pubmed    Pubmed Central
uBio Home | uBioRSS

WebSearchLiteratureMolecularImages

 uBio  Web Results 1 - 10 of about 2672600

Scientific:
   Acanthospermum humile (low starburr) 
   Ambrosia artemisiifolia (low ragweed) 
   Amelanchier humilis (low serviceberry) 
   Antennaria dimorpha (low pussytoes) 
   Apocynum (low dogbane) 
   Apocynum androsaemifolium pumilum pumilum (low dogbane) 
   Ardisia humilis (low shoebutton) 
   Arenaria humifusa (low sandwort) 
   Argythamnia humilis (low wildmercury) 
   Artemisia arbuscula (low sagebrush) 
   Artemisia arbuscula arbuscula (gray low sagebrush) 
   Asclepias pumila (low milkweed) 
   Asiocolotes depressus (Low Lying Gecko) 
   Aster radula radula (low rough aster) 
   Aster spectabilis (Low Showy Aster) 
   Astragalus lotiflorus (Low milkvetch) 
   Braya humilis (low northern-rockcress) 
   Callirhoe involucrata (low poppymallow) 
   Calystegia spithamaea (low false bindweed) 
   Calystegia spithamaea spithamaea (low false bindweed) 
   Campanula glomerata acaulis (Low Cluster Danesblood Be) 
   Carex concinna (low northern sedge) 
   Carex socialis (low woodland sedge) 
   Chenopodium chenopodioides (low goosefoot) 
   Chrysothamnus humilis (low rabbitbrush) 
   Chrysothamnus molestus (stickyfruit low rabbitbrush) 
   Chrysothamnus viscidiflorus axillaris (low rabbitbrush) 
   Chrysothamnus viscidiflorus lanceolatus (lanceleaf low rabbitbrush) 
   Chrysothamnus viscidiflorus planifolius (flatleaf low rabbitbrush) 
   Chrysothamnus viscidiflorus puberulus (hairy low rabbitbrush) 
   Convolvulus spithamaeus (Low Bindweed) 
   Cornus canadensis (Low Cornel) 
   Crotalaria pumila (low rattlebox) 
   Cryptantha pusilla (low cryptantha) 
   Cyperus pumilus (low flatsedge) 
   Dalea scandens (low prairieclover) 
   Dasyochloa pulchella (low woollygrass) 
   Delphinium nuttallianum (low larkspur) 
   Ericameria nana (low goldenbush) 
   Erigeron pumilus (low fleabane) 
   Euphorbia peplidion (low spurge) 
   Firmicutes (low GC Gram+) 
   Gayophytum humile (low groundsmoke) 
   Gnaphalium uliginosum (low cudweed) 
   Grindelia nana (Low Gumweed) 
   Gypsophila muralis (low babysbreath) 
   Helianthemum propinquum (low frostweed) 
   Hieracium gracile detonsum (low alpine hawkweed) 
   Ipomopsis pumila (low skyrocket) 
   Isolepis cernua (low bulrush) 
   Kyllinga pumila (low spikesedge) 
   Lathyrus pusillus (low peavine) 
   Lesquerella prostrata (low bladderpod) 
   Lupinus pusillus (low lupine) 
   Lythrum ovalifolium (low loosestrife) 
   Malva rotundifolia (low mallow) 
   Menodora heterophylla (low menodora) 
   Muhlenbergia curtifolia (low muhly) 
   Myriophyllum humile (low watermilfoil) 
   Panicum (low panicum sp) 
   Paronychia sessiliflora (low nailwort) 
   Paspalidium (low paspalums) 
   Penstemon humilis (low penstemon) 
   Penstemon humilis humilis (low penstemon) 
   Phacelia humilis (low phacelia) 
   Philonotis fontana caespitosa (low philonotis moss) 
   Polygala ramosa (low pinebarren milkwort) 
   Ranunculus pusillus (low spearwort) 
   Rosa virginiana (Low Rose) 
   Ruellia humilis (low ruellia) 
   Scleria verticillata (low nutrush) 
   Scleropodium cespitans (low scleropodium moss) 
   Senna obtusifolia (Low Senna) 
   Sphagnum compactum (low sphagnum) 
   Thelesperma caespitosum (low greenthread) 
...


Synonyms:
   Asiocolotes depressus (Low Lying Gecko) 

Broader Terms:
   Asiocolotes (Golubev's Geckos) 
   Low 

More Specific:
   Low firmicutes 
   Low gram-positive sulfur-oxidizing 
   Low milkvetch 
   Low squirrel 
   Low threshold vector 
   LŲw pine scale 
   low alpine hawkweed 
   low baby s-breath 
   low babysbreath 
   low bacteria 
   low bacteria walls 
   low bacterium 
   low bacterium wall 
   low beardtongue 
   low bladderpod 
   low bulrush 
   low bush blueberry 
   low catseye 
   low cryptantha 
   low cudweed 
   low daisy 
   low dogbane 
   low everlasting 
   low false bindweed 
   low firmicute environmental samples 
   low flatsedge 
   low fleabane 
   low frostweed 
   low goldenbush 
   low goosefoot 
   low gram-positive cellulolytic thermophile 
   low greenthread 
   low groundsmoke 
   low hop clover 
   low larkspur 
   low loosestrife 
   low lupine 
   low mallow 
   low menodora 
   low milkweed 
   low muhly 
   low nailwort 
   low northern sedge 
   low northern-rockcress 
   low nutrush 
   low panicum 
   low paspalums 
   low peavine 
   low penstemon 
   low phacelia 
   low philonotis moss 
   low pinebarren milkwort 
   low poppymallow 
   low prairie clover 
   low prairieclover 
   low pussytoes 
   low rabbitbrush 
   low ragweed 
   low rattlebox 
   low rough aster 
   low ruellia 
   low sagebrush 
   low sandwort 
   low scleropodium moss 
   low service-berry 
   low serviceberry 
   low shoebutton 
   low silverbush 
   low skyrocket 
   low spearwort 
   low sphagnum 
   low spikesedge 
   low spurge 
   low starburr 
   low water-milfoil 
... 
 
Latest Articles on Low from uBioRSS


Myriophyllum humile
USDA-NRCS PLANTS Database

External Resources:

Did you mean: Loou, Lou, Louwia, Lova, Love, Lovea, Loveus, Lovia, Lovis, Loviya, Lovor, Lowe, Lowea, Loweia, Lowia or louea?



1.  Conflict monitoring and attentional adjustment during binocular rivalry.LinkIT
Drew A, Torralba M, Ruzzoli M, Morís Fernández L, Sabaté A, Szabina Pápai M, Soto-Faraco S
The European journal of neuroscience, 2021
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

2.  [Testicular Cancer Screening in Men Aged 16 Years and Older: IQWiG ThemenCheck Health Technology Assessment Report on Medical, Economic, Social, Ethical, Legal and Organisational Aspects].LinkIT
Schnell-Inderst P, Laschkolnig A, Marckmann G, Antony D, Siebert U, M√ľhlberger N
Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)), 2021
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

3.  Rate of Anti-NMDA Receptor Encephalitis in Ovarian Teratomas.10.1055/s-0041-1740352?The rate of anti-N-methyl-D-aspartate receptor encephalitis (NMDARE) in ovarian teratomas is unknown. We aim to identify the prevalence of NMDARE as well as volumetric and histopathologic characteristics of ovarian teratomas in patients with versus without.?We performed a retrospective cohort study to identify patients with confirmed ovarian teratomas and the characteristics of teratomas in NMDARE compared with non-NMDARE patients. Patients aged between 0 and 21 years with confirmed histopathological diagnosis of ovarian teratoma after resection were included. The rate of NMDARE in ovarian teratomas was identified. Moreover, volumes of ovarian teratomas and the frequency of neuronal glial elements on histopathology in NMDARE versus non-NMDARE patients were assessed.?Five out of one-hundred-and-sixty-three (3.07%) patients with histopathology confirmed ovarian teratomas were diagnosed with NMDARE. Age was not different between the NMDARE (mean: 13.8 years, standard deviation: 3.9) and non-NMDARE groups (median: 14, interquartile range [IQR]: 5). Teratoma volumes from NMDARE patients were smaller than those of non-NMDARE patients (median 28.3?cm3 with IQR of 431.2 and median 182.8 with IQR of 635.0, respectively). Both age and NMDARE diagnosis were statistically significant variables in the analysis of variance on a multiple linear regression model. Age (p?=?0.013) had a positive correlation with teratoma size, whereas presence of NMDARE had a negative correlation (p?=?0.008).?The rate of NMDARE in ovarian teratomas is low and NMDARE patients have smaller teratomas than non-NMDARE. Further studies are needed to understand the timing of anti-NMDA receptor antibodies in teratomas and the development of NMDARE.Thieme. All rights reserved.LiJennifer HJHDepartment of Medicine, Emory University, Atlanta, Georgia, United States.MillaSarah SSSDivision of Pediatric Radiology, Department of Radiology, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, United States.Department of Radiology, Children's Hospital Colorado, Aurora, Colorado, United States.GombolayGrace YGY0000-0003-4830-7792Division of Neurology, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, United States.Division of Pediatric Radiology, Department of Radiology, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, United States.engJournal Article20211206GermanyNeuropediatrics81011870174-304XIMJennifer Li has no disclosures.Sarah Milla has no disclosures.Grace Gombolay receives salary support from the Centers for Disease Control and Prevention for the surveillance of acute flaccid myelitis.20211262030202112760202112760aheadofprint3487213310.1055/s-0041-174035234870926NBK575630University of Washington, SeattleSeattle (WA)GeneReviews¬ģ199319932021AdamMargaret PMPArdingerHolly HHHPagonRoberta ARAWallaceStephanie ESEBeanLora JHLJHMirzaaGhaydaGAmemiyaAnneAInternetMolybdenum Cofactor DeficiencyLinkIT
Li JH, Milla SS, Gombolay GY, , Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A, , Misko A, Mahtani K, Abbott J, Schwarz G, Atwal P, , Bennett MI, Allsop MJ, Allen P, Allmark C, Bewick BM, Black K, Blenkinsopp A, Brown J, Closs SJ, Edwards Z, Flemming K, Fletcher M, Foy R, Godfrey M, Hackett J, Hall G, Hartley S, Howdon D, Hughes N, Hulme C, Jones R, Meads D, Mulvey MR, O?Dwyer J, Pavitt SH, Rainey P, Robinson D, Taylor S, Wray A, Wright-Hughes A, Ziegler L
Neuropediatrics, 2021Dec06NeuropediatricsNeuropediatricsRate of Anti-NMDA Receptor Encephalitis in Ovarian Teratomas.10.1055/s-0041-1740352?The rate of anti-N-methyl-D-aspartate receptor encephalitis (NMDARE) in ovarian teratomas is unknown. We aim to identify the prevalence of NMDARE as well as volumetric and histopathologic characteristics of ovarian teratomas in patients with versus without.?We performed a retrospective cohort study to identify patients with confirmed ovarian teratomas and the characteristics of teratomas in NMDARE compared with non-NMDARE patients. Patients aged between 0 and 21 years with confirmed histopathological diagnosis of ovarian teratoma after resection were included. The rate of NMDARE in ovarian teratomas was identified. Moreover, volumes of ovarian teratomas and the frequency of neuronal glial elements on histopathology in NMDARE versus non-NMDARE patients were assessed.?Five out of one-hundred-and-sixty-three (3.07%) patients with histopathology confirmed ovarian teratomas were diagnosed with NMDARE. Age was not different between the NMDARE (mean: 13.8 years, standard deviation: 3.9) and non-NMDARE groups (median: 14, interquartile range [IQR]: 5). Teratoma volumes from NMDARE patients were smaller than those of non-NMDARE patients (median 28.3?cm3 with IQR of 431.2 and median 182.8 with IQR of 635.0, respectively). Both age and NMDARE diagnosis were statistically significant variables in the analysis of variance on a multiple linear regression model. Age (p?=?0.013) had a positive correlation with teratoma size, whereas presence of NMDARE had a negative correlation (p?=?0.008).?The rate of NMDARE in ovarian teratomas is low and NMDARE patients have smaller teratomas than non-NMDARE. Further studies are needed to understand the timing of anti-NMDA receptor antibodies in teratomas and the development of NMDARE.Thieme. All rights reserved.LiJennifer HJHDepartment of Medicine, Emory University, Atlanta, Georgia, United States.MillaSarah SSSDivision of Pediatric Radiology, Department of Radiology, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, United States.Department of Radiology, Children's Hospital Colorado, Aurora, Colorado, United States.GombolayGrace YGY0000-0003-4830-7792Division of Neurology, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, United States.Division of Pediatric Radiology, Department of Radiology, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, United States.engJournal Article20211206GermanyNeuropediatrics81011870174-304XIMJennifer Li has no disclosures.Sarah Milla has no disclosures.Grace Gombolay receives salary support from the Centers for Disease Control and Prevention for the surveillance of acute flaccid myelitis.20211262030202112760202112760aheadofprint3487213310.1055/s-0041-174035234870926NBK575630University of Washington, SeattleSeattle (WA)GeneReviews¬ģ199319932021AdamMargaret PMPArdingerHolly HHHPagonRoberta ARAWallaceStephanie ESEBeanLora JHLJHMirzaaGhaydaGAmemiyaAnneAInternetMolybdenum Cofactor DeficiencyengMiskoAlbertADepartment of NeurologyMassachusetts General HospitalHarvard Medical SchoolBoston, MassachusettsMahtaniKarishmaKAtwal Clinic: Genomic & Personalized MedicinePalm Beach, FloridaAbbottJessicaJAtwal Clinic: Genomic & Personalized MedicinePalm Beach, FloridaSchwarzGuenterGInstitute of BiochemistryDepartment of Chemistry & Center for Molecular MedicineCologne UniversityCologne, GermanyAtwalPaldeepPAtwal Clinic: Genomic & Personalized MedicinePalm Beach, FloridaReviewMolybdenum cofactor deficiency (MoCD) represents a spectrum, with some individuals experiencing significant signs and symptoms in the neonatal period and early infancy (termed early-onset or severe MoCD) and others developing signs and symptoms in childhood or adulthood (termed late-onset or mild MoCD). Individuals with early-onset MoCD typically present in the first days of life with severe encephalopathy, including refractory seizures, opisthotonos, axial and appendicular hypotonia, feeding difficulties, and apnea. Head imaging may demonstrate loss of gray and white matter differentiation, gyral swelling, sulci injury (typically assessed by evaluating the depth of focal lesional injury within the sulci), diffusely elevated T2-weighted signal, and panlobar diffusion restriction throughout the forebrain and midbrain with relative sparring of the brain stem. Prognosis for early-onset MoCD is poor, with about 75% succumbing in infancy to secondary complications of their neurologic disability (i.e., pneumonia). Late-onset MoCD is typically characterized by milder symptoms, such as acute neurologic decompensation in the setting of infection. Episodes vary in nature but commonly consist of altered mental status, dystonia, choreoathetosis, ataxia, nystagmus, and fluctuating hypotonia and hypertonia. These features may improve after resolution of the inciting infection or progress in a gradual or stochastic manner over the lifetime. Brain imaging may be normal or may demonstrate T2-weighted hyperintense or cystic lesions in the globus pallidus, thinning of the corpus callosum, and cerebellar atrophy.The diagnosis of molybdenum cofactor deficiency is established by identification of biallelic pathogenic variants in GPHN, MOCS1, MOCS2, or MOCS3, or when unavailable, of significantly reduced activity of the enzyme sulfite oxidase in cultured fibroblasts. However, due to low expression of sulfite oxidase in fibroblasts, differentiation between total and partial loss of enzyme activity is difficult to discern.Treatment of manifestations: Affected individuals are often placed on a cysteine-restricted diet, which typically includes low protein intake with restriction of whole natural protein; in those with MOCS1-related MoCD (MoCD type A), cyclic pyranopterin monophosphate (cPMP) daily infusion through an indwelling catheter (dose based on weight and age; each vial contains 9.5 mg) may be considered. Feeding therapy and consideration of gastrostomy tube placement in those with concerns about aspiration and/or persistent feeding issues. Thiamine supplementation (1.2 mg/day for infants; 50 mg/1x/day to 100 mg/2x/day for children/adolescents) for those with thiamine deficiency. Magnesium supplementation and standardized migraine prophylactics for those with headaches. Standard treatment for seizures, developmental delay / intellectual disability, spasticity/dystonia, and ectopia lentis. Surveillance: Routine measurement of essential amino acids in those on a low-cysteine low-protein diet. Assessment for new or progressive neurologic manifestations, measurement of growth parameters and head circumference, monitoring of developmental milestones, and assessment of mobility and self-help skills at each visit. At least annual ophthalmology evaluations. Neuropsychological testing and standardized quality-of-life assessments as clinically indicated. Agents/circumstances to avoid: Valproate should be avoided if possible, as sulfite intoxication impairs mitochondrial function in vitro. Evaluation of relatives at risk: For at-risk newborn sibs in whom prenatal testing was not performed, metabolic treatment should be initiated immediately and continued until such a time as the diagnosis has been excluded through molecular genetic testing or by measurement of serum uric acid and urinary: sulfite, s-sulfocysteine, xanthine, hypoxanthine, and uric acid.Molybdenum cofactor deficiency (MoCD) is inherited in an autosomal recessive manner. If both parents are known to be heterozygous for an MoCD-causing pathogenic variant, each sib of an affected individual has at conception a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Once the MoCD-causing pathogenic variants have been identified in an affected family member, carrier testing for at-risk relatives, prenatal testing for a pregnancy at increased risk, and preimplantation genetic testing are possible.Copyright ¬© 1993-2021, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.
Summary
Diagnosis
Clinical Characteristics
Genetically Related (Allelic) Disorders
Differential Diagnosis
Management
Genetic Counseling
Resources
Molecular Genetics
Chapter Notes
References
2021122
202112761202112761202112761ppublish34870926
34870925NBK57563510.3310/pgfar09150NIHR Journals LibrarySouthampton (UK)Pain self-management interventions for community-based patients with advanced cancer: a research programme including the IMPACCT RCT2021

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

4.  [Peer Support: Utilization and Benefit in Severe Mental Illness - Results from an Observational, Cross-Sectional Study].LinkIT
G√ľhne U, Richter D, Breilmann J, T√§umer E, Falkai P, Kilian R, Allg√∂wer A, Ajayi K, Baumg√§rtner J, Brieger P, Frasch K, Heres S, J√§ger M, K√ľthmann A, Putzhammer A, Schneewei√ü B, Schwarz M, Becker T, K√∂sters M, Riedel-Heller SG
Psychotherapie, Psychosomatik, medizinische Psychologie, 2021
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

5.  Can Prenatal and Postnatal Cell Phone Exposure Increase Adverse Maternal, Infant and Child Outcomes?LinkIT
Ashrafinia F, Moeindarbari S, Razmjouei P, Ghazanfarpour M, Najafi MN, Ghalibaf AAM, Abdi F
Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2021
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

6.  Teleoncology Orientation of Low-Income Breast Cancer Patients during the COVID-19 Pandemic: Feasibility and Patient Satisfaction.LinkIT
Miziara RA, Maesaka JY, Matsumoto DRM, Penteado L, Anacleto AADS, Accorsi TAD, Lima KA, Cordioli E, D Alessandro GS
Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2021
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

7.  Risk Factors Associated with Uterine Rupture and Dehiscence: A Cross-Sectional Canadian Study.LinkIT
Figueiró-Filho EA, Gomez JM, Farine D
Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2021
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

8.  Perinatal Outcomes and Factors Associated with Ethnic Group in cases of Preterm Birth: the Multicenter Study on Preterm Birth in Brazil.LinkIT
Fernandes KG, Souza RT, Passini R, Tedesco RP, Cecatti JG
Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2021
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0



1